Efficacy and safety of Tofacitinib in patients with active rheumatoid arthritis resistant to conventional therapy: Preliminary results of an open-label clinical trial

Efficacy and safety of Tofacitinib in patients with active rheumatoid arthritis resistant to conventional therapy: Preliminary results of an open-label clinical trial

Despite the advances in the therapy of rheumatoid arthritis (RA), which are associated with the use of biological anti-rheumatic drugs, the problemof effective treatment of RA is not still solved. Inclusion of new methods in treatment strategies, in particular the so-called «small molecules», i.e. s...

Full description

Saved in:
Bibliographic Details
Main Authors: E. L. Luchikhina, D. E. Karateev, N. V. Demidova, A. S. Musiyuk, E. N. Aleksandrova, A. A. Novikov, A. V. Smirnov, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2016-06-01
Series:Современная ревматология
Subjects:
rheumatoid arthritis
tofacitinib
small molecules
t2t strategy
Online Access:https://mrj.ima-press.net/mrj/article/view/679
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items